Suppr超能文献

催乳素基因多态性(-1149 G/T)与接受抗精神病药物治疗的精神分裂症患者的高催乳素血症有关。

Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.

作者信息

Ivanova Svetlana A, Osmanova Diana Z, Boiko Anastasia S, Pozhidaev Ivan V, Freidin Maxim B, Fedorenko Olga Yu, Semke Arkadiy V, Bokhan Nikolay A, Kornetova Elena G, Rakhmazova Lubov D, Wilffert Bob, Loonen Anton J M

机构信息

Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; National Research Tomsk Polytechnic University, Tomsk, Russian Federation.

Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation; National Research Tomsk State University, Tomsk, Russian Federation.

出版信息

Schizophr Res. 2017 Apr;182:110-114. doi: 10.1016/j.schres.2016.10.029. Epub 2016 Oct 21.

Abstract

BACKGROUND

Antipsychotic drugs can cause hyperprolactinemia. However, hyperprolactinemia was also observed in treatment-naive patients with a first schizophrenic episode. This phenomenon might be related to the role of prolactin as a cytokine in autoimmune diseases. Extrapituitary prolactin production is regulated by an alternative promoter, which contains the functional single nucleotide polymorphism -1149 G/T (rs1341239). We examined whether this polymorphism was associated with hyperprolactinemia in patients with schizophrenia.

METHOD

We recruited 443 patients with schizophrenia and 126 healthy controls. The functional polymorphism -1149 G/T (rs1341239) in the prolactin gene was genotyped with multiplexed primer extension, combined with MALDI-TOF mass spectrometry. Genotype and allele frequencies were compared between groups with the χ test and logistic regression models adjusting for covariates.

RESULTS

The frequency of genotypes and alleles in patients with schizophrenia did not differ from those in control subjects. A comparison between patients with schizophrenia with and without hyperprolactinemia revealed significantly higher frequency of the G allele in patients with hyperprolactinemia than in patients without it (χ=7.25; p=0.007; OR=1.44 [1.10-1.89]). Accordingly, patients with hyperprolactinemia carried the GG genotype more frequently than patients without hyperprolactinemia (χ=9.49; p=0.009). This association remained significant after adjusting the estimates for such covariates as sex, age, duration of the diseases and the dose of chlorpromazine equivalents.

CONCLUSION

This study revealed a significant association between the polymorphic variant rs1341239 and the development of hyperprolactinemia in patients with schizophrenia. The serum prolactin concentration in patients with schizophrenia treated with antipsychotics may provide an indication of the activity of the gene that regulates extrapituitary prolactin production which is believed to play a role in the immune system.

摘要

背景

抗精神病药物可导致高催乳素血症。然而,在初发精神分裂症且未接受治疗的患者中也观察到了高催乳素血症。这种现象可能与催乳素作为自身免疫性疾病中的一种细胞因子的作用有关。垂体外催乳素的产生受一个替代启动子调控,该启动子包含功能性单核苷酸多态性-1149 G/T(rs1341239)。我们研究了这种多态性是否与精神分裂症患者的高催乳素血症相关。

方法

我们招募了443例精神分裂症患者和126名健康对照者。采用多重引物延伸结合基质辅助激光解吸电离飞行时间质谱法对催乳素基因中的功能性多态性-1149 G/T(rs1341239)进行基因分型。采用χ检验和调整协变量的逻辑回归模型比较两组间的基因型和等位基因频率。

结果

精神分裂症患者的基因型和等位基因频率与对照者无差异。对有高催乳素血症和无高催乳素血症的精神分裂症患者进行比较,发现高催乳素血症患者中G等位基因的频率显著高于无高催乳素血症的患者(χ=7.25;p=0.007;OR=1.44[1.10-1.89])。相应地,高催乳素血症患者携带GG基因型的频率高于无高催乳素血症的患者(χ=9.49;p=0.009)。在对性别、年龄、病程和氯丙嗪等效剂量等协变量的估计进行调整后,这种关联仍然显著。

结论

本研究揭示了多态性变体rs1341239与精神分裂症患者高催乳素血症的发生之间存在显著关联。接受抗精神病药物治疗的精神分裂症患者的血清催乳素浓度可能提示调节垂体外催乳素产生的基因的活性,而该基因被认为在免疫系统中起作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验